Provided by Tiger Fintech (Singapore) Pte. Ltd.

Irhythm Technologies Inc.

100.34
-5.5800-5.27%
Post-market: 100.340.00000.00%19:36 EDT
Volume:405.55K
Turnover:40.51M
Market Cap:3.15B
PE:-27.63
High:102.95
Open:101.65
Low:96.66
Close:105.92
Loading ...

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

Simply Wall St.
·
04 Apr

Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock?

Zacks
·
02 Apr

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

GlobeNewswire
·
31 Mar

Tempus AI Surges 40% YTD: Are New Strategic Deals a Buy Signal?

Zacks
·
18 Mar

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

Zacks
·
18 Mar

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Blockhead
·
11 Mar

1 Growth Stock to Target This Week and 2 to Ignore

StockStory
·
05 Mar

Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?

Zacks
·
26 Feb

iRhythm Technologies Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
25 Feb

iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
22 Feb

iRhythm Technologies Faces Financial Risks from Convertible Debt Accounting Practices

TIPRANKS
·
22 Feb

IRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss

Dow Jones
·
22 Feb

Irhythm Technologies: Strong Financial Performance and Strategic Advantages Support Buy Rating

TIPRANKS
·
22 Feb

iRhythm price target raised to $145 from $111 at Truist

TIPRANKS
·
21 Feb

Truist Adjusts iRhythm Technologies' Price Target to $145 From $111, Keeps Buy Rating

MT Newswires Live
·
21 Feb

Stock Track | iRhythm Technologies Soars Over 6% on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
21 Feb

iRhythm Technologies Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
21 Feb

Stock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
21 Feb

iRhythm Technologies Is Maintained at Buy by Needham

Dow Jones
·
21 Feb

Strong Sales Growth and Strategic Expansion Drive Buy Rating for iRhythm Technologies

TIPRANKS
·
21 Feb